Merrimack Pharmaceuticals, Inc. announced the election of Russell T. Ray to its Board of Directors, effective January 1, 2015. Ray is a leading investment banker and venture capital investor in the life sciences sector, and has served as a director and advisor for many prominent companies in the healthcare sector during his 30 years of experience.
Ray began his career in investment banking as a member of the High Tech Emerging Growth Group at Merrill Lynch. After his time at Merrill Lynch, Ray spent twelve years at Deutsche Bank and its predecessor entities, BT Alex. Brown and Alex. Brown & Sons, as a Managing Director and Global Head of Healthcare Investment Banking. Ray then joined Credit Suisse First Boston and served as a Managing Director and Global Co-Head of Healthcare Investment Banking where he focused on providing strategic and financial advice to life sciences, healthcare services and medical device companies.
During his investment banking career, Ray successfully completed over 175 merger and financing transactions for leading healthcare companies in the United States, Europe and Israel. Currently, Ray serves as a Senior Advisor to HLM Venture Partners, a healthcare venture capital firm focused on investing in healthcare information technology, healthcare services and medical technology companies. Ray also serves as a Director of Allergan, Inc. and SWP Media, Inc. Read More